State-of-the-Art and Perspectives for Nanomaterials Combined with Nitric Oxide Donors: From Biomedical to Agricultural Applications
Source abstract
Abstract
The free radical nitric oxide (NO) is a signaling molecule that controls several important physiological and pathophysiological processes in mammals and in plants. In humans, the biological impacts of NO include, but are not limited to, key roles in cardiovascular, neurological, immunological, respiratory, and reproductive systems. In plants, NO modulates plant growth and development with important roles in plant defense against biotic and abiotic stress conditions. However, the administration of exogenous NO donors still faces limitations, mainly due to their instability and lack of bioavailability in the biological system. Recently, the combination of nanomaterials with NO donors has been extensively explored as a promising strategy to tailor the spatiotemporal release of therapeutic amounts of NO. Nanoscience offers smart approaches to deliver NO on demand for a particular application. Although this strategy has shown promising results, the combination of NO donors with nanomaterials is still limited to scientific studies and is less explored in agricultural applications compared with biomedical research. The current review summarizes the impact of NO and NO donors in biomedical research and agricultural applications and emphasizes the recent progress in the combination of nanotechnology and NO donors. The advantages, challenges, and drawbacks of this strategy are discussed in light of inspiring research on this exciting topic, aiming to translate these innovations into clinical/practical settings.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Polymer-Based Agricultural Enhancements · Nitric Oxide and Endothelin Effects
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Natural and Human Sciences, Federal University of ABC, Santo André, São Paulo 09210-580, Brazil
Mirscience Therapeutics, São Paulo, São Paulo 05653-000, Brazil
Department of Biodiversity, Institute of Biosciences, São Paulo State University (UNESP), Rio Claro, São Paulo 13506-900, Brazil
Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico · Fundação de Amparo à Pesquisa do Estado de São Paulo · Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
References (100+)
Show source-provided references
1. Seabra A. · 2017
2. 10.1097/ALN.000000000000257910.1097/ALN.0000000000002579 ↗
3. 10.1007/s00726-015-1986-110.1007/s00726-015-1986-1 ↗
4. 10.1016/S0039-6109(02)00207-410.1016/S0039-6109(02)00207-4 ↗
5. 10.1097/MOH.0b013e32833157f410.1097/MOH.0b013e32833157f4 ↗
6. 10.1152/ajpgi.1992.262.3.G37910.1152/ajpgi.1992.262.3.G379 ↗
7. 10.1016/j.niox.2022.06.00210.1016/j.niox.2022.06.002 ↗
8. 10.3390/ijms2124939310.3390/ijms21249393 ↗
9. 10.1016/j.vph.2006.08.00210.1016/j.vph.2006.08.002 ↗
10. 10.1126/science.147090310.1126/science.1470903 ↗
11. Ignarro L. · 2009
12. 10.1093/jxb/erx42010.1093/jxb/erx420 ↗
13. 10.3390/ijms23231495110.3390/ijms232314951 ↗
14. 10.1111/nph.1807310.1111/nph.18073 ↗
15. 10.12688/f1000research.19998.110.12688/f1000research.19998.1 ↗
16. 10.1073/pnas.180493211510.1073/pnas.1804932115 ↗
17. 10.1093/jxb/erz11710.1093/jxb/erz117 ↗
18. 10.1042/bj357059310.1042/bj3570593 ↗
19. 10.7717/peerj.1365110.7717/peerj.13651 ↗
20. 10.1007/BF0017277210.1007/BF00172772 ↗
21. 10.1016/j.bcp.2022.11532510.1016/j.bcp.2022.115325 ↗
22. 10.1016/j.jconrel.2022.10.01210.1016/j.jconrel.2022.10.012 ↗
23. 10.1002/med.2159910.1002/med.21599 ↗
24. 10.1161/01.CIR.0000142296.19558.9910.1161/01.CIR.0000142296.19558.99 ↗
25. 10.3109/0953710090315937510.3109/09537100903159375 ↗
26. 10.1016/j.niox.2022.08.00510.1016/j.niox.2022.08.005 ↗
27. 10.1093/jxb/erz35210.1093/jxb/erz352 ↗
28. 10.1016/j.niox.2016.09.00510.1016/j.niox.2016.09.005 ↗
29. 10.1126/scisignal.aad440310.1126/scisignal.aad4403 ↗
30. 10.3389/fpls.2020.0097010.3389/fpls.2020.00970 ↗
31. 10.1111/pce.1361710.1111/pce.13617 ↗
32. 10.1016/j.tplants.2016.12.00110.1016/j.tplants.2016.12.001 ↗
33. 10.1007/PL0000084710.1007/PL00000847 ↗
34. 10.1007/s00425-009-1057-510.1007/s00425-009-1057-5 ↗
35. 10.1016/j.mito.2011.03.00510.1016/j.mito.2011.03.005 ↗
36. 10.1105/tpc.109.07351010.1105/tpc.109.073510 ↗
37. 10.1002/advs.20170104310.1002/advs.201701043 ↗
38. 10.1021/acs.biomac.8b0006310.1021/acs.biomac.8b00063 ↗
39. Drug Approval Package: Nitrostat (Nitroglycerin Sublingual) NDA #21–134; U.S. FDA, 2000. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21134_Nitrostat.cfm (accessed 07-09-2023).
40. 10.3390/molecules19091531410.3390/molecules190915314 ↗
41. Drug Trials Snapshots: Vyzulta; U.S. FDA, 2017. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-vyzulta (accessed 07-09-2023).
42. 10.1016/j.ijpharm.2022.12246510.1016/j.ijpharm.2022.122465 ↗
43. 10.14719/pst.224810.14719/pst.2248 ↗
44. 10.1177/0391398823115742710.1177/03913988231157427 ↗
45. Sodium Nitroprusside Injection Fliptop Vial; Xiromed, LLC, 2021.
46. 10.1016/j.plaphy.2021.01.03710.1016/j.plaphy.2021.01.037 ↗
47. 10.2147/IJN.S27600110.2147/IJN.S276001 ↗
48. 10.1016/j.jvs.2007.09.00510.1016/j.jvs.2007.09.005 ↗
49. 10.1002/adhm.20210269210.1002/adhm.202102692 ↗
50. 10.4155/fso.15.4810.4155/fso.15.48 ↗
51. 10.1039/D1MA00532D10.1039/D1MA00532D ↗
52. 10.7150/thno.4957710.7150/thno.49577 ↗
53. 10.3390/ijms2002044910.3390/ijms20020449 ↗
54. 10.3390/ijms1907197910.3390/ijms19071979 ↗
55. 10.1039/D0TB00817F10.1039/D0TB00817F ↗
56. 10.3389/fenvs.2016.0002010.3389/fenvs.2016.00020 ↗
57. 10.1093/jxb/erad10710.1093/jxb/erad107 ↗
58. 10.1016/j.niox.2016.09.01010.1016/j.niox.2016.09.010 ↗
59. 10.1201/9781351104722-2110.1201/9781351104722-21 ↗
60. 10.3390/plants1123324510.3390/plants11233245 ↗
61. 10.1016/j.apsb.2022.11.01610.1016/j.apsb.2022.11.016 ↗
62. 10.1021/acsnano.3c0230310.1021/acsnano.3c02303 ↗
63. 10.1177/155798832090319110.1177/1557988320903191 ↗
64. 10.1016/j.niox.2008.04.00610.1016/j.niox.2008.04.006 ↗
65. 10.1016/j.jconrel.2021.10.01210.1016/j.jconrel.2021.10.012 ↗
66. 10.1016/j.bcp.2019.11374010.1016/j.bcp.2019.113740 ↗
67. 10.1016/j.biotechadv.2015.01.00510.1016/j.biotechadv.2015.01.005 ↗
68. 10.1021/acs.nanolett.0c0153210.1021/acs.nanolett.0c01532 ↗
69. 10.1016/j.msec.2021.11261610.1016/j.msec.2021.112616 ↗
70. 10.1016/j.colsurfb.2018.09.07810.1016/j.colsurfb.2018.09.078 ↗
71. 10.1039/D1TB01084K10.1039/D1TB01084K ↗
72. 10.1021/acsnano.2c0334810.1021/acsnano.2c03348 ↗
73. 10.1039/D3CC01226C10.1039/D3CC01226C ↗
74. 10.1039/C8SC03386B10.1039/C8SC03386B ↗
75. 10.1186/s12951-021-00989-z10.1186/s12951-021-00989-z ↗
76. 10.1039/C8NR03265C10.1039/C8NR03265C ↗
77. 10.1039/D0TB02626C10.1039/D0TB02626C ↗
78. 10.1021/acs.nanolett.2c0431210.1021/acs.nanolett.2c04312 ↗
79. 10.1007/s40820-020-00431-310.1007/s40820-020-00431-3 ↗
80. 10.1021/acsami.2c1588210.1021/acsami.2c15882 ↗
81. 10.1021/acs.molpharmaceut.2c0097310.1021/acs.molpharmaceut.2c00973 ↗
82. 10.1021/acsbiomaterials.9b0138410.1021/acsbiomaterials.9b01384 ↗
83. 10.1016/j.virusres.2020.19820210.1016/j.virusres.2020.198202 ↗
84. 10.3390/jof602008510.3390/jof6020085 ↗
85. 10.1016/j.niox.2019.09.00710.1016/j.niox.2019.09.007 ↗
86. 10.1016/j.niox.2021.04.00810.1016/j.niox.2021.04.008 ↗
87. 10.1039/D0NR07484E10.1039/D0NR07484E ↗
88. 10.3389/fcimb.2021.68415010.3389/fcimb.2021.684150 ↗
89. 10.1002/mabi.20200024810.1002/mabi.202000248 ↗
90. 10.1016/j.scitotenv.2022.15508510.1016/j.scitotenv.2022.155085 ↗
91. 10.1016/j.msec.2020.11093310.1016/j.msec.2020.110933 ↗
92. 10.1021/acsbiomaterials.9b0168510.1021/acsbiomaterials.9b01685 ↗
93. 10.1016/j.msec.2019.10974110.1016/j.msec.2019.109741 ↗
94. 10.1016/j.bioactmat.2022.10.00810.1016/j.bioactmat.2022.10.008 ↗
95. 10.1016/j.ijpharm.2021.12122010.1016/j.ijpharm.2021.121220 ↗
96. 10.1016/j.cej.2022.13812910.1016/j.cej.2022.138129 ↗
97. 10.2174/138161282466618020910562510.2174/1381612824666180209105625 ↗
98. 10.1002/adhm.20230024710.1002/adhm.202300247 ↗
99. 10.1016/j.actbio.2022.02.02910.1016/j.actbio.2022.02.029 ↗
100. 10.1016/j.ijpharm.2021.12122010.1016/j.ijpharm.2021.121220 ↗